Concepedia

Palmitoylethanolamide in the Treatment of Chronic Pain Caused by Different Etiopathogenesis

Antonio Gatti, Marzia Lazzari, Valentina Gianfelice, Annarita Di Paolo, Elisabetta Sabato, Alessandro Sabato

Pain Medicine · 2012 · 97 citations · 38 references

DOI

Abstract

In this study, PEA was effective and safe in the management of chronic pain in different pathological conditions.

References

38

Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment

Harald Breivik, Vittorio Ventafridda, Rob Cohen et al. · European Journal of Pain · 2005 · 5.4K citations · Full text

Interactions between the immune and nervous systems in pain

Ke Ren, Ronald Dubner · Nature Medicine · 2010 · 797 citations

, , +9

The burden of neuropathic pain: results from a cross‐sectional survey

Anne M. McDermott, Thomas Toelle, David J. Rowbotham et al. · European Journal of Pain · 2005 · 368 citations

Possible Pathogenesis of Painful Intervertebral Disc Degeneration

Baogan Peng, Jianhua Hao, Shuxun Hou et al. · Spine · 2006 · 317 citations

The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and PPARγ receptors and neurotrophic factors

Barbara Costa, Francesca Comelli, Isabella Bettoni et al. · Pain · 2008 · 283 citations

, , +22